Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 23, 2016 08:02 ET | Source: Celtaxsys Inc.

Celtaxsys to Present at Jefferies Healthcare and JMP Securities Life Sciences Conferences

ATLANTA, GA--(Marketwired - May 23, 2016) - Celtaxsys, Inc., a clinical stage pharmaceutical company focused on developing anti-inflammatory therapies for cystic fibrosis (CF) lung disease and...
May 03, 2016 08:03 ET | Source: Celtaxsys, Inc.

Celtaxsys Begins EU Enrollment for CF Lung Function Preservation Trial of Acebilustat Anti-Inflammatory Therapy for Cystic Fibrosis

ATLANTA, GA--(Marketwired - May 03, 2016) - Celtaxsys, a clinical stage drug development company focused on advancing therapies for patients with rare and orphan inflammatory diseases, announced...
December 01, 2015 08:03 ET | Source: Celtaxsys Inc.

Celtaxsys to Present at 27th Annual Piper Jaffray Healthcare Conference

ATLANTA, GA--(Marketwired - December 01, 2015) - Celtaxsys, a clinical stage drug development company focused on advancing foundational medicine for patients suffering from orphan inflammatory...
October 01, 2015 08:03 ET | Source: Celtaxsys Inc.

Celtaxsys to Present Clinical Data on Oral Acebilustat at North American Cystic Fibrosis Conference: Key Inflammation Biomarkers Reduced in CF Patients

ATLANTA, GA--(Marketwired - October 01, 2015) - Celtaxsys, a clinical stage drug development company focused on advancing care for patients suffering from orphan inflammatory diseases, announced today...